ORCA
Online Research @ CardiffÂ
Browse by All Cardiff Authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 3.
Richman, Susan D., Adams, Richard Alexander  ORCID: https://orcid.org/0000-0003-3915-7243, Quirke, Phil, Butler, Rachel, Hemmings, Gemma, Chambers, Phil, Roberts, Helen, James, Michelle D., Wozniak, Sue, Bathia, Riya, Pugh, Cheryl, Maughan, Timothy Stanley and Jasani, Bharat
2015.
Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial.
Journal of Clinical Pathology
69
(1)
, pp. 35-41.
10.1136/jclinpath-2015-203097
|
|
|
|
Smith, Chris, Fisher, D., Claes, B., Maughan, T. S., Idziaszczyk, Shelley, Peuteman, G., Harris, Rebecca, James, Michelle D., Meade, A., Jasani, Bharat, Adams, Richard A. ORCID: https://orcid.org/0000-0003-3915-7243, Kenny, S., Kaplan, R., Lambrechts, D. and Cheadle, Jeremy P. ORCID: https://orcid.org/0000-0001-9453-8458
2013.
Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximab.
Clinical Cancer Research
19
(15)
, pp. 4104-4113.
10.1158/1078-0432.CCR-12-2581
|
|
|
Maughan, Timothyn S., Adams, Richard A. ORCID: https://orcid.org/0000-0003-3915-7243, Smith, Chris, Meade, Angela M., Seymour, Matthew T., Wilson, Richard H., Idziaszczyk, Shelley A., Harris, Rebecca, Fisher, David, Kenny, Sarah L., Kay, Edward, Mitchell, Jenna K., Madi, Ayman, Jasani, Bharat, James, Michelle D., Bridgewater, John, Kennedy, M. John, Claes, Bart, Lambrechts, Diether, Kaplan, Richard and Cheadle, Jeremy P. ORCID: https://orcid.org/0000-0001-9453-8458
2011.
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.
The Lancet
377
(9783)
, pp. 2103-2114.
10.1016/S0140-6736(11)60613-2
|
|
|
Cardiff University Information Services